RWE Studies - Teamit

Experts in the scientific management of pharmacoepide-
miology research and regulatory science.

Experts in the scientific management of pharmacoepidemiology research and regulatory science

Real-World Evidence (RWE) Studies

We provide scientific management in pharmacoepidemiology, safety and effectiveness studies of medicines and vaccines based on real-world evidence

Active Studies

Pfizer Comirnaty PASS

Sponsor: Pfizer
Network: VAC4EU
Duration: 2021-2025
Partners: 12
Countries: 5
Scientific Coordinator: UMCU
Protocol: EUPAS41623

Learn more

Pfizer Comirnaty Myo/Pericarditis PASS

Sponsor: Pfizer
Network: VAC4EU
Duration: 2023-2025
Partners: 12
Countries: 5
Scientific Coordinator: UMCU
Protocol: EUPAS47708

Learn more

Pfizer Bivalent PASS

Sponsor: Pfizer
Network: VAC4EU
Duration: 2024-2026
Partners: 10
Countries: 5
Scientific Coordinator: UMCU
Protocol: EUPAS108847

Learn more

Pfizer Abrysvo PASS

Sponsor: Pfizer
Network: VAC4EU
Duration: 2024-2029
Partners: 13
Countries: 7
Scientific Coordinator: UMCU
Protocol: Pass 12

Learn more

J&J Jcovden PASS

Sponsor: Janssen -Cilag International NVr
Network: VAC4EU
Duration: 2022-2025
Partners: 6
Countries: 2
Scientific Coordinator: UMCU
Protocol: EUPAS45362

Learn more

UCB Evenity PASS

Sponsor: UCB Pharma S.A
Network: EU-ADR Alliance
Duration: 2020-2026
Partners: 7
Countries: 5
Scientific Coordinator: Oxford
Protocol: EUPAS36005

Learn more

Closed Studies

Covid-Vaccine-Monitor (CVM)

Sponsor: EMA
Network: EUPE&PV Network and VAC4EU
Duration: 2021-2023
Partners: 29
Countries: 14
Scientific Coordinator: UMCU
Protocol: EUPAS39798 - EUPAS42467 - EUPAS42504

Learn more

Covid Vaccines Effectiveness (CoVE)

Sponsor: EMA
Network: EUPE&PV Network and VAC4EU
Duration: 2023
Partners: 17
Countries: 4
Scientific Coordinator: AEMPS
Protocol: EUPAS47725

Learn more

GVDN COVID-19 Association (GCoVS)

Sponsor: CDC
Network: GVDN
Duration: 2024-2026
Partners: 12
Countries: 10
Scientific Coordinator: UMCU

Learn more

Sanofi Vidprevtyn beta PASS (Feasibility)

Sponsor: Sanofi
Network: VAC4EU
Duration: 2024-2026
Partners: 7
Countries: 6
Scientific Coordinator: BPE

Learn more

Vaccines Safety Framework (SAFETY-VAC)

Sponsor: EMA
Network: EUPE&PV Network and VAC4EU
Duration: 2023-2025
Partners: 17
Countries: 8
Scientific Coordinator: UMCU
Protocol: EUPAS1000000193, EUPAS1000000233, EUPAS1000000288

Learn more

Research Networks Management

We are experts in the coordination, governance and business development of multistakeholder international networks dedicated to pharmacoepidemiology research.

Vaccine monitoring collaboration for Europe (VAC4EU) is an international network that fosters real world evidence creation on vaccine coverage, safety, and effectiveness. VAC4EU has 24 members, from 9 European countries, and 17 data partners covering an overall population of 152 million.

Our role:

Business Development

Scientific Research Management

Quality Framework

Communication, Dissemination & Outreach Strategy

The European Pharmacoepidemiology and Pharmacovigilance (EU PE&PV) Research Network conducts research projects on the real-world effectiveness and safety of medicines and the impact of medicines' regulatory interventions. The network brings together more than 50 research centers in 21 European countries.

Our role:

Scientific research management

Business Developmen

Quality Framework

Communication, Dissemination & Outreach Strategy

The Exploring and Understanding Adverse Drug Reactions (EU-ADR) Alliance is a European collaboration framework that conducts multi-database studies to answer pharmacoepidemiologic and drug safety questions, covering about 20 million active population.

Our role:

Business Development

Scientific Research Management

Regulatory Science

As experts in regulatory science, we guide, manage, and provide scientific support to EMA regulatory procedures at different stages of development of medicines or therapies, devices, and methodologies.

Experts in the scientific management of pharmacoepide- miology research and regulatory science.

Experts in the scientific management of pharmacoepidemiology research and regulatory science

Real-World Evidence (RWE) Studies

We provide scientific management in pharmacoepidemiology, safety and effectiveness studies of medicines and vaccines based on real-world evidence

Active Studies

Pfizer Comirnaty PASS

Pfizer Comirnaty PASS

Pfizer Comirnaty Myo/Pericarditis PASS

Pfizer Comirnaty Myo/Pericarditis PASS

Pfizer Bivalent ​ PASS

Pfizer Bivalent PASS

Pfizer Abrysvo PASS

Pfizer Abrysvo PASS

J&J Jcovden PASS

J&J Jcovden PASS

UCB Evenity PASS

UCB Evenity PASS

Closed Studies

Covid-Vaccine-Monitor (CVM)​

Covid-Vaccine-Monitor (CVM)​

Covid Vaccines Effectiveness (CoVE)​

Covid Vaccines Effectiveness (CoVE)​

GVDN COVID-19 Association (GCoVS)​

GVDN COVID-19 Association (GCoVS)​

Sanofi Vidprevtyn beta PASS (Feasibility)​

Sanofi Vidprevtyn beta PASS (Feasibility)​

Vaccines Safety Framework (SAFETY-VAC)​

Vaccines Safety Framework (SAFETY-VAC)​

Research Networks Management ​

We are experts in the coordination, governance and business development of multistakeholder international networks dedicated to pharmacoepidemiology research.

Vaccine monitoring ​collaboration for Europe (VAC4EU) is an international network that fosters real world evidence creation on vaccine coverage, safety, and effectiveness. VAC4EU has 24 members, from 9 European countries, and 17 data partners covering an overall population of 152 million.

Our role:

Business Development

Scientific Research Management

Quality Framework

Communication, Dissemination & Outreach Strategy

Our role:

Scientific research management

Business Developmen

Quality Framework

Communication, Dissemination & Outreach Strategy

The Exploring and Understanding Adverse Drug Reactions (EU-ADR) Alliance is a ​European collaboration framework that conducts multi-database studies to answer pharmacoepidemiologic and drug safety questions, covering about 20 million active population.

Our role:

Business Development

Scientific Research Management

Regulatory Science

As experts in regulatory science, we guide, manage, and provide scientific support to EMA regulatory procedures at different stages of development of medicines or therapies, devices, and methodologies.

EMPOWERING COLLABORATIVE RESEARCH AND INNOVATION FOR A HEALTHIER FUTURE

Barcelona Health Hub Recinte Modernista de Sant Pau Sant Antoni Maria Claret, 167 08025 Barcelona (Spain) +34 930 180 163

Follow us

Follow us

© 2025 - Teamit Research

Experts in the scientific management of pharmacoepide-
miology research and regulatory science.

Pfizer Bivalent PASS

Covid-Vaccine-Monitor (CVM)

Covid-Vaccine-Monitor (CVM)

Covid Vaccines Effectiveness (CoVE)

Covid Vaccines Effectiveness (CoVE)

GVDN COVID-19 Association (GCoVS)

GVDN COVID-19 Association (GCoVS)

Sanofi Vidprevtyn beta PASS (Feasibility)

Sanofi Vidprevtyn beta PASS (Feasibility)

Vaccines Safety Framework (SAFETY-VAC)

Vaccines Safety Framework (SAFETY-VAC)

Research Networks Management

Vaccine monitoring collaboration for Europe (VAC4EU) is an international network that fosters real world evidence creation on vaccine coverage, safety, and effectiveness. VAC4EU has 24 members, from 9 European countries, and 17 data partners covering an overall population of 152 million.

The Exploring and Understanding Adverse Drug Reactions (EU-ADR) Alliance is a European collaboration framework that conducts multi-database studies to answer pharmacoepidemiologic and drug safety questions, covering about 20 million active population.

As experts in regulatory science, we guide, manage, and provide scientific support to EMA regulatory procedures at different stages of development of medicines or therapies, devices, and methodologies.

Barcelona Health Hub
Recinte Modernista de Sant Pau
Sant Antoni Maria Claret, 167 
08025 Barcelona (Spain)
+34 930 180 163